Shanghai United Imaging Healthcare Co., Ltd. (SHA:688271)

SHA:688271 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	10,012	9,884	11,171	9,024	7,147	5,696
Other Revenue	416.04	416.04	239.52	214.11	106.39	64.83
Revenue	10,428	10,300	11,411	9,238	7,254	5,761
Revenue Growth (YoY)	-9.71%	-9.73%	23.52%	27.36%	25.91%	93.36%
Cost of Revenue	5,342	5,287	6,082	4,845	3,693	2,950
Gross Profit	5,086	5,013	5,328	4,394	3,561	2,811
Selling, General & Admin	2,421	2,384	2,173	1,761	1,350	1,166
Research & Development	1,716	1,757	1,725	1,304	967.03	752.44
Other Operating Expenses	-234.75	-226.81	-281.35	-218.46	-164.54	-127.96
Operating Expenses	4,055	4,054	3,675	2,941	2,173	1,812
Operating Income	1,031	959.42	1,654	1,453	1,389	999.79
Interest Expense	-5.19	-2.52	-0.13	-6.42	-3.3	-49.05
Interest & Investment Income	194.93	214.35	285.02	108.13	90.39	51.92
Currency Exchange Gain (Loss)	8.37	8.37	-14.69	15.46	4.85	2.75
Other Non Operating Income (Expenses)	-11.96	-9.99	-11.94	-5.91	-4.35	-29.15
EBT Excluding Unusual Items	1,217	1,170	1,912	1,564	1,476	976.26
Gain (Loss) on Sale of Investments	-9.5	37	-6.06	28.5	-10.59	4.91
Gain (Loss) on Sale of Assets	-0.87	-0.87	0.01	-0.14	-0.17	0.08
Asset Writedown	-2.68	-0.55	-0.4	-	-1.71	-1.78
Other Unusual Items	145.55	146.5	236.57	327.25	233.77	175.54
Pretax Income	1,350	1,352	2,142	1,920	1,698	1,155
Income Tax Expense	104.28	109.78	164.5	269.71	294.03	218.36
Earnings From Continuing Operations	1,246	1,242	1,978	1,650	1,404	936.64
Minority Interest in Earnings	23.15	19.95	-3.46	6	13.68	-33.73
Net Income	1,269	1,262	1,974	1,656	1,417	902.92
Net Income to Common	1,269	1,262	1,974	1,656	1,417	902.92
Net Income Growth	-36.82%	-36.09%	19.21%	16.86%	56.96%	-
Shares Outstanding (Basic)	819	819	823	756	723	695
Shares Outstanding (Diluted)	819	819	823	756	723	695
Shares Change (YoY)	-0.54%	-0.39%	8.78%	4.58%	3.99%	-
EPS (Basic)	1.55	1.54	2.40	2.19	1.96	1.30
EPS (Diluted)	1.55	1.54	2.40	2.19	1.96	1.30
EPS Growth	-36.48%	-35.83%	9.59%	11.73%	50.93%	-
Free Cash Flow	-2,298	-2,565	-943.31	-58.52	595.72	2,607
Free Cash Flow Per Share	-2.81	-3.13	-1.15	-0.08	0.82	3.75
Dividend Per Share	0.200	0.200	0.250	0.201	-	-
Dividend Growth	-20.00%	-20.00%	24.38%	-	-	-
Gross Margin	48.77%	48.67%	46.70%	47.56%	49.09%	48.80%
Operating Margin	9.89%	9.31%	14.49%	15.73%	19.14%	17.35%
Profit Margin	12.17%	12.25%	17.30%	17.93%	19.54%	15.67%
Free Cash Flow Margin	-22.04%	-24.90%	-8.27%	-0.63%	8.21%	45.26%
EBITDA	1,421	1,334	1,968	1,716	1,625	1,189
EBITDA Margin	13.63%	12.95%	17.24%	18.58%	22.41%	20.64%
D&A For EBITDA	389.69	374.51	313.79	263.3	236.53	189.01
EBIT	1,031	959.42	1,654	1,453	1,389	999.79
EBIT Margin	9.89%	9.31%	14.49%	15.73%	19.14%	17.35%
Effective Tax Rate	7.73%	8.12%	7.68%	14.05%	17.32%	18.91%
Revenue as Reported	10,428	10,300	11,411	9,238	7,254	-
Advertising Expenses	-	53.37	29.17	13.31	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.